- beauty
- industrial
- pharma
Amphetamine
CAS 300-62-9 · 100/100 · High conf.
Also registered as 3 other CAS numbers
60-15-1 · 17108-96-2 · 96332-84-2
Concern score
Amphetamine in plain language
On cosmetic ingredient lists it appears as “N-adamantanoyl tyramine”.
Also known as N-adamantanoyl tyramine · N-cyclohexanoyl tyramine · N-nicotinoyl dopamine · N-nicotinoyl tyramine · Octopamine · Amfetamine
Show all 45 names
(±)-desoxynorephedrine · 1-Phenylpropan-2-amine · Amphetamine, dl- · Norephedrane · (+/-)-.alpha.-methylphenethylamine · (+/-)-1-Phenyl-2-aminopropane · (+/-)-Desoxynorephedrine · (+/-)-Phenylisopropylamine · (+/-)-α-Methylphenethylamine · (+/-)-α-Methylphenylethylamine · (+/-)-β-Phenylisopropylamine · (±)-.alpha.-methylphenethylamine · .beta.-aminopropylbenzene · 1-PHENYL-2-AMINOPROPANE · Adzenys er · Adzenys xr-odt · Amfetamin · Actedron · Allodene · Anorexide · Anorexine · Benzeneethanamine, .alpha.-methyl-, (+/-)- · Benzeneethanamine, .alpha.-methyl-, (±)- · Benzeneethanamine, .alpha.-methyl- · Benzeneethanamine, α-methyl- · DEA no. 1100 · Dyanavel · Desoxynorephedrine · Elastonon · Fenopromin · Mydayis (mixed salts of a single entity) · Phenedrine · Propisamine · Psychedrine · Raphetamine · Rhinalator · Simpatedrin · Sympatedrine · dl-Amphetamine
We don't have a plain-language description for Amphetamine yet.
Recorded functional uses: Pharmaceutical
- Critical concern: no hazard classifications on record. It is banned in EU cosmetics.
Why it's flagged
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe is prohibited in cosmetic products under Annex II of the EU Cosmetics Regulation (EC) 1223/2009.
RestrictedEU EC — banned
The score describes this ingredient's chemical identity — its hazard profile from published classifications and regulatory status — not the safety of any product it appears in.
Regulation
Restrictions first, then routine listings from published regulatory sources.
- In marketed US drugs
- EU Annex II — prohibited
- EU prohibited in cosmetics
- Found in consumer products
- Industrial
- View source →banned
EUEC
Annex II of EU Cosmetics Regulation (EC) 1223/2009: substances prohibited in cosmetic products.
EUCosIngActiveCosmetics Regulation annex II / ref 21.
- Cosmetics Regulation annex II / ref 21.Source →
USEPAcommercial use observedEPA CPDat observed this chemical in 3 composition records across product categories including Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Pharmaceutical.
- EPA CPDat observed this chemical in 3 composition records across product categories including Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Pharmaceutical.Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 23 active drug products and 23 total products.
- FDA NDC lists this ingredient in 23 active drug products and 23 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Expert safety opinions
No expert opinion on file for Amphetamine. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.
SCCS
EU Scientific Committee on Consumer Safety
No SCCS opinion on file.
CIR
Cosmetic Ingredient Review (US expert panel)
No CIR safety assessment on file.
Evidence & sources
No graded research studies for Amphetamine yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Where this comes from
- Open →
CosIng
regulatory · updated 2026-09-23
- Open →
EU CosIng Cosmetics Regulation Annexes
regulatory · updated 2011-03-09
- Open →
EPA Chemical and Products Database
exposure · updated September 2018
- Open →
EPA DSSTox Identifiers
chemistry · updated 2025-12-29
- Open →
FDA National Drug Code Directory
regulatory · updated 2027-12-31
- Open →
FDA GSRS UNII
registry · updated 2026-02-26
- Open →
openFDA Substance
registry · updated 2026-05-24
- Open →
PubChem Live Enrichment
chemistry · updated 2026-05-17
Allergen profile
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
- DairyContains · Oral (ingested)
Source: chemindex_name_match
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
Where it has been recorded
How often FDA National Drug Code directory has listed Amphetamine in a product composition. These are source records, not Greenveil catalog products.
Source records
23
Typical roles